FA
ABBV icon

Financial Advisors’s AbbVie ABBV Stock Holding History

Financial Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$963K Sell
4,158
-142
-3% -$28.9K 0.17% 30
2025
Q2 		$798K Sell
4,300
-150
-3% -$27.9K 0.15% 34
2025
Q1 		$932K Hold
4,450
– – 0.18% 30
2024
Q4 		$791K Hold
4,450
– – 0.15% 31
2024
Q3 		$879K Hold
4,450
– – 0.17% 30
2024
Q2 		$763K Hold
4,450
– – 0.16% 28
2024
Q1 		$810K Hold
4,450
– – 0.17% 29
2023
Q4 		$690K Buy
4,450
+1
+0% +$146 0.15% 30
2023
Q3 		$663K Sell
4,449
-195
-4% -$28.6K 0.16% 29
2023
Q2 		$626K Sell
4,644
-27
-0.6% -$3.96K 0.15% 31
2023
Q1 		$744K Buy
4,671
+3
+0.1% +$459 0.19% 29
2022
Q4 		$754K Sell
4,668
-200
-4% -$30.7K 0.21% 27
2022
Q3 		$681K Sell
4,868
-180
-4% -$25.8K 0.24% 28
2022
Q2 		$773K Hold
5,048
– – 0.27% 27
2022
Q1 		$818K Hold
5,048
– – 0.26% 28
2021
Q4 		$683K Sell
5,048
-60
-1% -$7.09K 0.21% 35
2021
Q3 		$551K Buy
5,108
+200
+4% +$22.9K 0.19% 40
2021
Q2 		$553K Sell
4,908
-100
-2% -$11.3K 0.19% 39
2021
Q1 		$542K Buy
5,008
+532
+12% +$56.9K 0.22% 36
2020
Q4 		$480K Sell
4,476
-125
-3% -$12K 0.21% 36
2020
Q3 		$403K Hold
4,601
– – 0.21% 43
2020
Q2 		$452K Hold
4,601
– – 0.25% 32
2020
Q1 		$351K Buy
4,601
+103
+2% +$8.77K 0.24% 39
2019
Q4 		$398K Buy
4,498
+77
+2% +$6.39K 0.23% 41
2019
Q3 		$335K Hold
4,421
– – 0.21% 43
2019
Q2 		$321K Hold
4,421
– – 0.21% 44
2019
Q1 		$356K Hold
4,421
– – 0.24% 41
2018
Q4 		$408K Buy
+4,421
New +$389K 0.33% 30

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Financial Advisors's ABBV Position: Q3 2025 in Review

Financial Advisors reduced its AbbVie (ABBV) stake by 3.3% in Q3 2025, selling an estimated $28.9K and leaving 4,158 shares worth $963K. The position accounts for 0.17% of the portfolio, ranked #30.

Financial Advisors first reported a position in ABBV in Q4 2018 and has held it in 28 quarters since. 3,906 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Financial Advisors held 4,158 shares of AbbVie worth $963K as of Q3 2025.
  • Financial Advisors sold 142 AbbVie shares in Q3 2025, an estimated $28.9K.
  • AbbVie made up 0.17% of Financial Advisors's portfolio in Q3 2025, its #30 holding.
  • Financial Advisors first reported a position in AbbVie in Q4 2018 and has held it in 28 quarters since.
  • 3,906 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Financial Advisors's 13F filing for Q3 2025, filed 7 Nov 2025.